Bespoke Extracts (BSPK) Cash & Equivalents (QoQ) (2011 - 2025)
Bespoke Extracts (BSPK) Cash & Equivalents (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,128.39% |
| Jun 30, 2025 | -95.51% |
| Mar 31, 2025 | -49.65% |
| Dec 31, 2024 | 181.21% |
| Sep 30, 2024 | -13.50% |
| Jun 30, 2024 | 71.97% |
| Mar 31, 2024 | 118.19% |
| Jun 30, 2023 | -55.40% |
| Mar 31, 2023 | -82.13% |
| Dec 31, 2022 | 125.06% |
| Sep 30, 2022 | -55.82% |
| Jun 30, 2022 | -73.95% |
| Nov 30, 2021 | -43.68% |
| Aug 31, 2021 | -86.56% |
| May 31, 2021 | -83.42% |
| Feb 28, 2021 | 94.22% |
| Nov 30, 2020 | 103.98% |
| Aug 31, 2020 | 41,960.80% |
| May 31, 2020 | -99.33% |
| Feb 29, 2020 | -70.16% |